1[1]Brozovic A,Simaga S,Osmak M. Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia [J]. Neoplasma,2001,48(2)∶99-103.
2[2]Gerner EW, Hersh EM, Pennington M, et al. Heat-inducible vectors for use in gene therapy[J]. Int J Hyperthermia, 2000,16(2)∶171-181.
3[3]Huang Q, Hu JK, Lohr F, et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy [J]. Cancer Research, 2000, 60∶3435-3439.
7[8]Tsuboi M, Nagai K, Saitoh H, et al. The local hyperthermochemotherapy for pleural carcinomatosis[J]. Nippon Kyobu Geka Gakkai Zasshi, 1992 ,40(8)∶1195-1202.
8[9]Miura T, Endo Y, Matumoto Y, et al. Intra-arterial infusion chemotherapy in combination with microwave hyperthermia for cancer of head of pancreas and liver metastasis--a case of 16 years survival[J]. Gan To Kagaku Ryoho, 2000, 27(12)∶1794-1800.
9[10]Wiedemann GJ, d'Oleire F, Knop E, et al. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma[J]. Cancer Res, 1994 ,54(20)∶5346-5350.
10[11]Raaphorst GP. Fundamental aspects of hyperthermic biology[A]. In Field SB, Hand JW (eds): An Introduction to the Practical Aspects of Clinical Hyperthermia[M]. London: Taylor and Francis ,1990. 10-54.
6Extra JM, Marty M, Brienza S,et al. Pharmacokinetics and safety profile of oxaliplatin [J]. Semin Oncol,1998,25(2 Suppl 5):13--22.
7Beliber H,de Gramont A. Oxaliplatin plus 5-fluorou-racil : clinical experience in patients with advanced colorectal cancer [J]. Semin Oncol, 1998,25 (2 Suppl 5) :32--39.
